Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Dec 16 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-16-2021-7

Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 16, 2021, titled "Zydus receives Orphan Drug Designation from US FDA for ZY-19489, a novel compound to treat malaria".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases